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Analysis of amniotic fluid specimens for common chromosome disorders using
interphase fluorescence in situ hybridization
Tariq Moatter1, Zahida Khilji2, Farzana Murad3, Shama Munim4
Departments of Pathology and Microbiology1-3, Obstetrics and Gynecology4, Aga Khan University, Karachi.

Abstract
Objective: The aim of the study was to examine the usage of multi colour FISH technology as an adjunct to conventional cytogenetics for the prenatal diagnosis of aneuploidy in interphase nuclei from high risk pregnancies.
Methods: Amniotic fluid samples were collected for interphase FISH analysis using DNA probes for chromosomes 13, 18, 21, X and Y. All the probes were directly labeled with fluorescent molecules. Fluorescent signals
were observed under a microscope. A minimum of 100 nuclei with defined hybridization signals were counted
for each probe.
Results: Seventy-eight amniotic fluid samples were received for FISH analysis. The average age of mothers and
their gestational ages were 33 years and 17.5 weeks respectively. Triple test screening was positive in 39.5% of
the women followed by advanced maternal age and ultrasonographic abnormalities. Interphase FISH was performed on 76 specimens whereas 2 samples were rejected because of blood contamination. Aneuploidy was
identified in 6 out of 76 specimens. Two cases of trisomy 21, two cases of trisomy 18 and one case of monosomy X were detected. In addition, one case showed 10% mosaicism for trisomy 21. Initially 4 (5.3%) samples
were uninformative due to technical reasons but gave acceptable scoring signals when reanalyzed.
Conclusion: This study has demonstrated that interphase FISH is a rapid and a reliable technique for the enumeration of chromosome number in uncultured amniocytes. Clinicians can use it for making early decisions necessary for the management of high risk pregnancies ultimately saving patients from anxiety and psychological
stress (JPMA 57:189;2007).

Introduction
Prenatal diagnosis for chromosomal abnormalities is primarily accomplished by conventional cytogenetic banding of
metaphase chromosomes of foetal cells obtained from
amniotic fluid. Chromosomal aneuploidies including trisomy 13, 18 and 21, monosomy X and 47, XXY account for
more than 80% of live born cytogenetic abnormalities.1,2
Cytogenetic analysis is associated with technical difficulties. A major disadvantage of the conventional cytogenetics
is the time taken for culture of foetal cells and it range
between 10 days to 3 weeks and in some cases culture failure can result which necessitate another invasive procedure.3 Foetal cells for chromosome diagnosis are obtained
either by amniocentesis which is done around 16 weeks of
gestation or chorionic villus sampling at about 9-11 weeks
of gestation. Both these procedures carry an associated risk
of 0.1-0.5% for abortion.4
The time required for chromosomal analysis might
place significant clinical or psychological burden on the
patient. Interphase fluorescence in situ hybridization technology in such cases can provide rapid and accurate diagnosis of aneuploidies.5-7 FISH involves hybridization of
selected chromosome specific DNA sequences that have
been labeled with fluorescent dyes to chromosome preparations. In 1991, the first developed probes were derived from
DNA of flow-sorted whole chromosomes and used for prenatal diagnosis of trisomy 13, 18 or 21 on uncultured amniotic fluid cell nuclei.8 Several studies have shown that FISH
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was highly effective for rapidly determining the number of
specific chromosomes in interphase cells, within 48 hours
compared to conventional cytogenetics which usually takes
8-10 day.9,10 In 2004, the United Kingdom National
Screening Committee recommended that the new screening
program for trisomies 13, 18 and 21 need not include karyotyping and can offer prenatal diagnosis for Down's syndrome with FISH or PCR as rapid diagnostic tests.11
Chromosomal abnormalities lead to a significant
genetic disease burden on our society, especially due to
lack of awareness among the general population and also
because of lack of diagnostic and management facilities.
To our knowledge this is the first report from Pakistan
which presents data on the use of multicolor commercially available FISH probes. The aim of the present study
was to examine in high risk pregnancies usage of multicolor FISH technology as an adjunct to conventional
cytogenetics for the prenatal diagnosis of aneuploidy in
interphase nuclei.

Material and Methods
From January 2004 to December 2005, amniotic
fluid samples were collected from women who had reported to the clinics at the Aga Khan University Hospital. FISH
was not performed on samples if visible blood contamination was present. The gestational age at amniocentesis and
the indications for testing were recorded. Indications for
testing included advanced maternal age, abnormal values of
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biochemical markers, foetal anomalies observed during
ultrasound scan, previous child with Down's syndrome or
children with chromosomal abnormalities in the family and
parents with chromosomal rearrangements. FISH for aneuploidy of chromosomes 13, 18, 21, X and Y was performed
using Aneuvysion assay kit according to the manufacturer's
instructions (Vysis, Abbott, USA).

Slide preparation
Approximately 5 ml of the amniotic fluid obtained
by amniocentesis was spun and the cell pellet was resuspended in 5 ml of trypsin/EDTA and incubated at 37°C
water bath. Following centrifugation and 0.56% KCl pretreatment, fixative was added drop by drop to the cells. The
suspension was then centrifuged and resuspended in 100 µl
fresh fixative, 10 µl of which was used for slide preparation.
Slides were then pretreated in 2X SSC for 20 min at 60oC
and later digested with pepsin prepared in 0.01N HCl for 20
min at 37oC. Subsequent to rinsing in phosphate buffered
saline (PBS) pH 7.5, slides were fixed in 0.95% formaldehyde and then finally washed in PBS at room temperature
for 5 min. The specimens were dehydrated through a graded series of ethanol (70%, 85% and 100%) and following air
drying step, DNA was denatured in 50% formamide at 73±1
oC for 7 min. Next the slides were placed in 70% ethanol jar
for 1 min and this step was repeated with 85% and 100%
ethanol then excess ethanol was drained from the slides.

DNA probes
Slides were placed on a 45oC slide warmer and then
10 µl of each well mixed centromeric enumeration probe
(CEP) 18/X/Y and locus specific identifier (LSI) 13/21
probes were applied on two separate well defined areas.
Cover slips were placed over the probe solution and sealed
with rubber cement. The slides were hybridized at 37°C in
a hybridization chamber (Hybrite, Vysis, Abbott, USA) for
at least 16 hours. Next day after removing the rubber
cement the slides were washed in 0.4X SSC/0.3% NP-40 at
73±1oC for 2 min. The slides were air dried in the dark, then
to each target area 10 µl of DAPI II (125 ng/ml in antifade)
counterstain, was applied before covering it with a glass
coverslip. The signals were enumerated using a Nikon
E800 microscope with single band pass filters for Spectrum
orange, Spectrum green, Spectrum aqua and DAPI that
allow visualization of orange, green, aqua signals against a
blue background according to the manufacturer's instructions. A minimum of 100 nuclei with defined hybridization
signals were enumerated. Cases with aberrant FISH signals
were considered as inconclusive and were not counted.

Results
A total of 78 amniotic fluid samples were received in
our molecular cytogenetics laboratory from Jan 2004 - Dec
2005 for prenatal analysis of aneuploidies in high risk pregnancies. In two cases samples were rejected because of contamination with maternal red blood cells. The age of the
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mothers varied from 22 to 45 years (mean 33 years). At the
time of amniocentesis gestational age ranged between 16-21
weeks (mean 17.5 weeks). Several indications for FISH
assays were recorded (Table). The main referral reason was
positive triple test screening results which accounted for
approximately 39.5% whereas high maternal age and ultrasonographic abnormalities were indicated in 25% and
11.8% cases respectively. Among the ultrasonography
abnormalities the most common were pleural effusion,
nuchal thickening (range 5.2-8.4 mm) heart defect, skeletal
dysplasia and omphalocoele. Surprisingly, 23.7% women
opted for screening because of the presence of a child with
Down's syndrome in the family.
When compared to conventional karyotyping which
takes 10 to 20 days (mean time 14 days) FISH assay was
completed within 24-48 hours and were mostly reported
within 36 hours after the receipt of the sample. Signals from
both CEP (X, Y, 18) and LSI (13, 21) probes were clearly
defined and easily recognized under the microscope.
Moreover, signal from chromosome 18 probe was more diffuse and stringy compared to compact and sharp signals
from LSI probes (Figure). In FISH preparations, nuclei of
amniocytes showed well defined margins and were evenly
stained with DAPI. In all sample preparations 100-200
nuclei were screened for all type of probes. The results of
the FISH assay were considered uninformative if there was
undetermined hybridization pattern or technical difficulties
were encountered in doing the analysis. Numerical aberrations were identified in 6 out of 76 specimens. There were
two cases of trisomy 21, two cases of trisomy 18, one case
Table. Indications for prenatal diagnosis.
Number

Percentage

Triple test screening positive

Indication

30

39.5

Advanced maternal age

19

25

Previous Down syndrome child

18

23.7

9

11.8

76

100

Abnormal ultrasound findings
Total

A

B

Figure. (a) A representative photograph of an amniocyte nucleus hybridized with chromosome 13
(green color) and 21(red color) specific LSI probes. Three red signals point toward trisomy 21. (
b) An interphase nucleus shows three signals of chromosome 18 specific CEP probe (aqua blue)
indicative of Edward's syndrome.

of monosomy X and one sample mosaic for trisomy 21.
The mosaic sample was repeated to confirm the result. A
FISH image from a case of trisomy 21 is shown in figure 1a,
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it demonstrates three signals (red) for chromosome 21 and
two signals (green) for chromosome 13. Figure 1b, shows a
FISH image of Edward's syndrome with three chromosome
18 signals (aqua blue). Overall 70 FISH specimen were normal, initially 4 (5.3%) were uninformative due to technical
reasons, when these samples were reanalyzed satisfactory
results were obtained.

Discussion
Conventional cytogenetics was first used to show
chromosomal aneuploidy in 1959 by studies of Lejeune and
colleagues, who described an extra chromosome in cultured
fibroblasts from patients with Down's syndrome.12
Additional chromosomal syndromes which involved sex
chromosomes including Turner syndrome were also
described in 1959.13 Amniocentesis was first performed in
1952 and in 1972 it became the standard for obtaining foetal
cells and today the most common reason for prenatal diagnosis is increased risk of having a child with trisomy 21.14
Standard cytogenetics is associated with a number of
technical difficulties. The major disadvantage of karyotyping is the long turnaround time to obtain the test results due
to the cell culture requirement. This delay puts women
under increased anxiety and depression. In addition, fear of
a false positive result also leads to psychological pressure.
According to Rausch and colleagues, this anxiety was the
cause of decreased participation in maternal serum screening in subsequent pregnancies.15 Studies have shown that
awaiting cytogenetic results has been determined to be a
most anxiety provoking aspect of prenatal diagnostic procedures and this concern is often reported by physicians as a
reason for not offering prenatal screening to women.16,17
In 1992, FISH assay on uncultured amniocytes was
used for detection of numerical aberrations in high risk
pregnancies as a choice for patients with increased emotional and psychological pressure.18,19 Klinger et al in 1992
were the first to study applications of FISH on interphase
nuclei of amniocytes using probes for 13, 18, 21 X and Y
followed by a larger study carried out by Ward et al in
1993.18,20 Since then many studies have been published in
the literature. Hulten et al predicted a risk for false positive
result is less than 1 in 30 000 and that of a false negative
result to be 1 in 4000.21 FISH was shown to diagnose aneuploidies within 24-48 hours following amniocentesis which
decreases the time interval between sampling and diagnosis.
This is of tremendous value in prenatal diagnosis of urgent
high-risk pregnancies. After extensive clinical validation,
the Food and Drug Administration has approved
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Aneuvysion FISH assay for the detection of aneuploidies of
chromosome 13, 18, 21, X and Y22 in 1999. Presently, FISH
is the most common types of molecular method for prenatal
diagnosis because of its short turn-around time which provides a major benefit for pregnancy management especially
in emotionally distressed women who have a previous
Down's child. As observed in the present study, a large number (23%) of women who have opted for FISH based prenatal screening had a previous child with Down's syndrome. In
2004, the UK National Screening Committee recommended
FISH for screening for Down's syndrome as an independent
test.11 Therefore, it is important that all high risk pregnancies based on indications including abnormal ultrasonography, advanced maternal age, biochemical screening and a
history of Down's syndrome in the family must undergo prenatal screening. This would protect the parents from emotional trauma and financial liability for special care and
treatment for the child in future. These factors stress the
need for rapid results to the clinician and patient leading to
better pregnancy and anxiety management. In this study one
mosaic sample showed 10% of nuclei carrying 3 signals of
LSI 21, whereas no direct relationship was found between
the degree of mosaicism judged by FISH and conventional
cytogenetics In some studies it has been proposed that it
might be due to variations in signals which can be attributed
to parameters such as sample quality, slide preparation and
hybridization or detection efficiency rather than to low level
mosaicism.23
In spite of its rapid technological advantages FISH
has certain limitations compared to standard karyotyping
which can detect structural chromosomal abnormalities and
gives a complete chromosome picture undetectable by present FISH approaches. Maternal cell contamination may
cause problems in FISH assay. It has been estimated that 12% of amniotic fluids contain visible blood stained which
can lead to false negative diagnosis of foetal aneuploidy.24
In a study carried out by Jobanputa et al presence of maternal cell contamination was approxiamtely 2% (range 0% 10%) estimated from the number of nuclei with XX signals
in karyotypically male samples.25 Therefore, as a precautionary measure laboratories should discard any heavily
blood contaminated samples.
In conclusion, FISH usage on interphase nuclei of
amniocytes is beneficial for early diagnosis of genetic disorders. Moreover, FISH assay is rapid and technically easy
to perform, it should be considered for the genetic diagnosis all management of high risk pregnancies in Pakistan.
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